一上市公司公告：高管自愿降薪，最高50%！

Core Viewpoint - Jiangsu Shuoshi Biotechnology Co., Ltd. announced voluntary salary reductions for its executives and board members to support operational cost optimization and enhance competitiveness amid challenging global economic conditions [1][3]. Salary Reduction Details - The honorary chairman, Fang Yongsheng, and the chairman and general manager, Wang Guoqiang, will have their annual salaries reduced by 50% starting from August 15, 2025 [2][3]. - Other executives, including Liu Zhonghua and Hu Tongyuan, will see a 40% reduction, while the financial director, Meng Yuanyuan, and employee supervisors will have reductions of 10% and 5%, respectively [2][3]. Company Performance Context - Shuoshi Biotechnology experienced significant revenue growth during the pandemic, with revenues soaring from 289 million yuan in 2019 to 5.535 billion yuan in 2022, but faced a dramatic decline in 2023 with revenues dropping to 403 million yuan, a 92.72% decrease year-over-year [4][5]. - The company reported a net loss of 374 million yuan in 2023, marking a 120.45% decline compared to the previous year [4][5]. Future Strategies - The company aims to continue optimizing operations and enhancing market competitiveness through cost reduction and efficiency improvement measures [3][4].